REGENXBIO Inc.

(RGNX) Trade

By |

Profile

Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.

Contact Information

Website: www.regenxbio.com
Email: ir@regenxbio.com
Main Phone: +1 240 552-8181
Address: 9600 Blackwell Road
Address 2: Suite 210
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NGS
CEO: Kenneth T. Mills
Employees: 139
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 68.60 $ 1.05 (1.55%)
Last Price 68.60 Change $ 1.05 Change % 1.55 Tick N/A
Bid 68.45 Bid Size 200.00 Ask 68.65 Ask Size 200.00
Open 67.60 High 68.90 Low 64.60 Prev Close 67.55
Last Trade Volume 368,907 52 Wk Hi 68.60 52 Wk Low 17.60
Market Cap 2.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 31,936,013.00 EPS (TTM) 1.39 PE Ratio 48.60 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 97
Number of Buys 9 34
Number of Sells 21 63
Net Activity -32500 133842
Last 10 Buys Shares
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Last 10 Sell Shares
Donald J. Hayden 1,000
Donald J. Hayden 1,000
Kenneth T. Mills 1,000
Kenneth T. Mills 1,000
Kenneth T. Mills 1,000
Vittal Vasista 1,000
Vittal Vasista 1,000
Vittal Vasista 1,000
Donald J. Hayden 1,000
Donald J. Hayden 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 90 90 90 90
Low Target Price Estimate 35 35 35 35
Mean Target Price Estimate 50.17 50.17 50.17 53.17
Standard Deviation 20.19 20.19 20.19 20.78
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.79 1.79 1.79 1.79